April 2, 2026

Science Chronicle

A Science and Technology Blog

April 2, 2026

Science Chronicle

A Science and Technology Blog

WHO

EditorialLung cancerSmokingTobaccoWHOWorld Health Organisation

Editorial: The ways of tobacco companies

For several decades, tobacco companies across the world vehemently denied and blatantly deceived and misled people about the dangers of

Read More
EditorialPictorial warningSmokingTobaccoWHO

Editorial: Smoking reveals a patchy record

Even as the prevalence of daily smoking among men in India has come down from about 34 to 23 per

Read More
PolioWHOWorld Health Organisation

Why oral polio vaccination must for India-bound Pakistanis

With no cases of polio being reported for three consecutive years, India will be declared as polio-free by the WHO

Read More
TuberculosisWHOWorld Health Organisation

‘In 2003, RNTCP had eight lines in the guidelines that related to TB in children’

After years of neglect by the WorldPu Health Organisation and almost all the national tuberculosis programmes [NTP] across the world,

Read More
FDATuberculosisWHOWorld Health Organisation

Clinical trials on child-friendly bedaquiline MDR-TB drug for children initiated

“Before the BPCA [Best Pharmaceuticals for Children Act] and the PREA [Paediatric Research Equity Act] became law, more than 80

Read More
TuberculosisWHOWorld Health Organisation

‘Nuances of childhood TB are never taught in medical schools’

If diagnosing tuberculosis in children, particularly those aged under five years, is fraught with problems, health-care workers at different levels

Read More
TuberculosisWHOWorld Health Organisation

Child-friendly, first-line TB combination drugs will be available in 2016: Dr. Mel Spigelman

Dr. Mel Spigelman, President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance) is regarded

Read More
TuberculosisWHOWorld Health Organisation

TB in children

  Childhood TB has been neglected for decades, but in the past few years the WHO has begun to realise

Read More
TuberculosisWHOWorld Health Organisation

Second-line TB drugs: ‘It is more difficult to assess adverse effects in children’

  Prof. H. Simon Schaaf,  a clinical researcher from the Department of Paediatrics and Child Health, Faculty of Health Sciences,

Read More
TuberculosisWHOWorld Health Organisation

Malnourished children in India below three years are underdosed for first-line TB drugs

“The ultimate goal of evidence-based drug treatment is to produce a desired pharmacological response in a predictable manner and also

Read More
EditorialMillennium Development GoalTuberculosisWHOWorld Health Organisation

Editorial: Missing TB cases in India

Although tuberculosis killed 1.3 million people across the globe in 2012 and nearly 8.6 million developed the disease, the world

Read More
TuberculosisWHOWorld Health Organisation

Why the true burden of paediatric TB remains unknown

“Measurement is the first step that leads to control and eventually to improvement. If you can’t measure something, you can’t

Read More
TuberculosisWHOWorld Health Organisation

Paediatric TB: should Xpert molecular test replace smear microscopy?

Unlike adults, children under five years of age are particularly vulnerable to getting infected with TB and may develop the

Read More